These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
495 related items for PubMed ID: 14745528
1. PET imaging in pediatric Hodgkin's lymphoma. Hudson MM, Krasin MJ, Kaste SC. Pediatr Radiol; 2004 Mar; 34(3):190-8. PubMed ID: 14745528 [Abstract] [Full Text] [Related]
2. Role of FDG-PET in the definition of involved-field radiation therapy and management for pediatric Hodgkin's lymphoma. Robertson VL, Anderson CS, Keller FG, Halkar R, Goodman M, Marcus RB, Esiashvili N. Int J Radiat Oncol Biol Phys; 2011 Jun 01; 80(2):324-32. PubMed ID: 20646867 [Abstract] [Full Text] [Related]
3. Whole-body MRI for staging and interim response monitoring in paediatric and adolescent Hodgkin's lymphoma: a comparison with multi-modality reference standard including 18F-FDG-PET-CT. Latifoltojar A, Punwani S, Lopes A, Humphries PD, Klusmann M, Menezes LJ, Daw S, Shankar A, Neriman D, Fitzke H, Clifton-Hadley L, Smith P, Taylor SA. Eur Radiol; 2019 Jan 01; 29(1):202-212. PubMed ID: 29948084 [Abstract] [Full Text] [Related]
5. Fluorine-18 fluorodeoxyglucose positron emission tomography, gallium-67 scintigraphy, and conventional staging for Hodgkin's disease and non-Hodgkin's lymphoma. Wirth A, Seymour JF, Hicks RJ, Ware R, Fisher R, Prince M, MacManus MP, Ryan G, Januszewicz H, Wolf M. Am J Med; 2002 Mar 01; 112(4):262-8. PubMed ID: 11893364 [Abstract] [Full Text] [Related]
6. Fluorine-18 fluorodeoxyglucose PET/CT patterns of extranodal involvement in patients with Non-Hodgkin lymphoma and Hodgkin's disease. Even-Sapir E, Lievshitz G, Perry C, Herishanu Y, Lerman H, Metser U. Radiol Clin North Am; 2007 Jul 01; 45(4):697-709, vii. PubMed ID: 17706534 [Abstract] [Full Text] [Related]
7. [18F]Fluorodeoxyglucose positron emission tomography for detection of bone marrow involvement in children and adolescents with Hodgkin's lymphoma. Purz S, Mauz-Körholz C, Körholz D, Hasenclever D, Krausse A, Sorge I, Ruschke K, Stiefel M, Amthauer H, Schober O, Kranert WT, Weber WA, Haberkorn U, Hundsdörfer P, Ehlert K, Becker M, Rössler J, Kulozik AE, Sabri O, Kluge R. J Clin Oncol; 2011 Sep 10; 29(26):3523-8. PubMed ID: 21825262 [Abstract] [Full Text] [Related]
8. Positron emission tomography (PET) for staging and evaluation of response to treatment in patients with Hodgkin's disease. Wiedmann E, Baican B, Hertel A, Baum RP, Chow KU, Knupp B, Adams S, Hör G, Hoelzer D, Mitrou PS. Leuk Lymphoma; 1999 Aug 10; 34(5-6):545-51. PubMed ID: 10492078 [Abstract] [Full Text] [Related]
9. The role of 18F-FDG PET and 18F-FDG PET/CT in the evaluation of pediatric Hodgkin's lymphoma and non-Hodgkin's lymphoma. Qiu L, Chen Y, Wu J. Hell J Nucl Med; 2013 Aug 10; 16(3):230-6. PubMed ID: 24137577 [Abstract] [Full Text] [Related]
10. Comparison of 18F-fluoro-2-deoxyglucose positron emission tomography and gallium-67 citrate scintigraphy for detecting malignant lymphoma. Shen YY, Kao A, Yen RF. Oncol Rep; 2002 Aug 10; 9(2):321-5. PubMed ID: 11836600 [Abstract] [Full Text] [Related]
11. Comparison of 18F-FDG-PET and standard procedures for the pretreatment staging of children and adolescents with Hodgkin's disease. Kabickova E, Sumerauer D, Cumlivska E, Drahokoupilova E, Nekolna M, Chanova M, Hladikova M, Kodet R, Belohlavek O. Eur J Nucl Med Mol Imaging; 2006 Sep 10; 33(9):1025-31. PubMed ID: 16565847 [Abstract] [Full Text] [Related]